Form 4: Intuitive Surgical EVP Brian Miller Sells Shares Under 10b5-1 Trading Plan

Sentiment:

SEC Form 4 Filing


Brian Edward Miller, EVP & Chief Digital Officer of Intuitive Surgical, sold 2,553 shares of common stock at $400 per share on May 16, 2024, under a pre-arranged 10b5-1 trading plan.

Summary

  • Brian Edward Miller, an EVP & Chief Digital Officer at Intuitive Surgical Inc. (ISRG), sold 2,553 shares of common stock on May 16, 2024.
  • The sale was executed at a price of $400 per share.
  • Following the transaction, Miller directly owns 9,619 shares of Intuitive Surgical common stock.
  • The sale was conducted under a pre-arranged trading plan that complies with SEC Rule 10b5-1, which expires on December 9, 2024.

Sentiment

Score: 5

Explanation: The document is a routine SEC filing related to an executive stock sale under a pre-arranged trading plan. It doesn't inherently indicate positive or negative sentiment about the company's performance.

Future Outlook

The document does not contain any specific forward-looking statements regarding the company's future performance. The sale was conducted under a pre-arranged trading plan.

Industry Context

Executive stock sales are a common occurrence in publicly traded companies. They can be driven by various factors, including personal financial planning. The use of a 10b5-1 trading plan allows insiders to sell shares over a period of time without being accused of trading on non-public information.

Comparison to Industry Standards

  • Executive compensation practices, including stock sales, are closely monitored in the medical device industry.
  • Companies like Stryker (SYK) and Medtronic (MDT) also have executives who periodically sell shares.
  • The use of 10b5-1 plans is a standard practice to ensure compliance with insider trading regulations.

Stakeholder Impact

  • The stock sale may have a minor impact on shareholders, but it is unlikely to be significant given the relatively small number of shares sold and the use of a 10b5-1 trading plan.

Key Dates

DateDescription
05/16/2024Date of stock sale transaction.
05/17/2024Date of signature on the Form 4 filing.
12/09/2024Expiration date of the 10b5-1 trading plan.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.